Cti Biopharma reported $0 in Sales Revenues for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Applied Genetic Technologies AGTC:US $ 0M 0.5M
Baxter International BAX:US $ 3226M 128M
Bristol Myers Squibb BMY:US $ 11624M 79M
Cytori Therapeutics CYTX:US $ 0M 0M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Geron GERN:US $ 0.11M 0M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Northwest Biotherapeutics NWBO:US 350K 66K
Novartis NOVN:VX SF 13367M 73M
Novartis NVS:US $ 13367M 73M
Seattle Genetics SGEN:US $ 424.06M 35.58M
Teva Pharmaceutical Industries TEVA:US $ 3887M 23M
YTE INCY:US $ 812.99M 107.28M